Abstract
6-GINGEROL FOR CANCER THERAPY- AN IN SILICO APPROACH
Manikesh Kumar*, Priyanka James, M. R. Shylaja and P. A. Nazeem
ABSTRACT
The natural polyphenolic alkanone 6-gingerol, a major pharmacologically active component of ginger has anti-inflammatory and antitumoral properties. Its potent anti-tumor activity has been reported in a variety of cancer types, including breast, pancreatic, gastric, colon and colorectal cancer and certain hematological malignancies. In a cellular milieu, binding of 6-gingerol with a protein could suppress the cancer cell growth and affect the dynamics of protein-protein interaction thereby altering the structure and function of the protein. In the present study, we identified the potential binding proteins of 6- gingerol for various types of cancer. 6-gingerol was docked to targets – epidermal growth factor receptor (EGFR), oestrogen receptor (ER), Cyclooxygenases (COX-2), Cyclin-dependent kinases (CDKs), and p90 ribosomal protein kinase 2 (RSK2) with the Docking software Discovery studio and docking based virtual screening was attempted.
[Full Text Article] [Download Certificate]WJPLS CITATION
All | Since 2019 | |
Citation | 422 | 322 |
h-index | 9 | 7 |
i10-index | 4 | 2 |
INDEXING
NEWS & UPDATION
BEST PAPER AWARDS
World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .
Best Article of current issue
Download Article : Click here